Exercise for Parkinson's Disease
(HI-LITE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the best exercise routine for people with mid-stage Parkinson's disease (PD). It compares high-volume dance exercises, moderate-volume dance exercises, and moderate-volume walking to identify which method best improves movement, physical activity levels, and overall health. Participants with PD symptoms such as stiffness, slow movement, or tremors, who experience relief from their medications, might be suitable for this trial. As an unphased trial, it offers participants the chance to contribute to valuable research that could improve exercise recommendations for Parkinson's disease.
Will I have to stop taking my current medications?
The trial requires participants to be observed while not taking their antiparkinsonian medications to avoid certain side effects and fluctuations. This means you will need to stop these medications during specific observation periods.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that partnered dance aerobic exercise (PDAE) is generally well-tolerated by people with Parkinson's disease. Studies have found that PDAE can reduce "OFF-time" (when medication isn't working well) and improve quality of life. No major safety issues have been reported for PDAE, whether done in high or moderate amounts, suggesting it is a safe option for people with Parkinson's.
For moderate volume walking (MV-WALK), research indicates that moderate aerobic exercise, like walking, helps improve balance and walking ability. It is considered safe for people with Parkinson's, with no major reports of negative effects. Walking is often recommended for its overall health benefits and easy-to-manage intensity.
Both partnered dance and walking exercises are safe, with research supporting their use in improving symptoms and overall well-being in people with Parkinson's.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for Parkinson's Disease because they explore innovative, non-pharmacological methods to improve movement and balance. Unlike standard treatments that often rely on medication to manage symptoms, these approaches use dance and walking as interactive, physical therapies. The High Volume Partnered Dance Aerobic Exercise (HV-PDAE) and the Moderate Volume Partnered Dance Aerobic Exercise (MV-PDAE) offer unique social and rhythmic elements, with dance adapted specifically for older adults with balance impairments. Participants engage in Argentine tango-inspired movements with partners, which can enhance coordination. Meanwhile, the Moderate Volume Walking (MV-WALK) arm provides a structured yet flexible walking routine aimed at improving gait. Collectively, these methods emphasize physical engagement and social interaction, which can provide holistic benefits beyond those offered by typical medical interventions.
What evidence suggests that this trial's treatments could be effective for Parkinson's disease?
This trial will compare different exercise interventions for Parkinson's disease. Studies have shown that partnered dance aerobic exercise (PDAE) reduces OFF-time in people with Parkinson's disease (PD). OFF-time refers to periods when symptoms are not well-controlled. In this trial, participants may receive either high-volume or moderate-volume PDAE. Research indicates that both high and moderate amounts of PDAE improve quality of life and movement abilities in people with PD. Evidence suggests that PDAE is more effective than simple walking programs for these improvements. However, another group in this trial will engage in moderate-volume walking, which also benefits participants by improving walking speed and gait. Regular moderate-intensity walking can help manage the disease and increase physical activity levels. Each exercise type in this trial has its own strengths in managing PD symptoms.23456
Who Is on the Research Team?
Madeleine E. Hackney, PhD
Principal Investigator
Atlanta VA Medical and Rehab Center, Decatur, GA
Are You a Good Fit for This Trial?
This trial is for veterans over 40 with moderate Parkinson's disease (stages 2 to 3), who can walk at least 10 feet and have a certain level of cognitive function. They must not have severe depression, major psychiatric illness, significant hearing loss, or serious heart conditions. Participants should benefit from Parkinson's medication and be able to commit to the study duration without long absences.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in Partnered Dance Aerobic Exercise (PDAE) or Walking for 52 weeks, with varying frequency and duration based on group assignment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- HV-PDAE: High Volume Partnered Dance Aerobic Exercise
- MV-PDAE: Moderate Volume Partnered Dance Aerobic Exercise
- MV-WALK: Moderate Volume Walking
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor